Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. NAFLD patients are at higher risk of developing Non-alcoholic steatohepatitis (NASH), which ...

Excessive intake of sucrose is a major driver of obesity and other diseases, such as non-alcoholic fatty liver diseases (NAFLD) and the more severe non-alcoholic steatohepatitis (NASH). In addition, a ...

Please provide your email address to receive an email when new articles are posted on . Irregular meal patterns increased the risk for NAFLD and related metabolic conditions. Time-restricted eating ...

Non-alcoholic steatohepatitis (NASH) is a potentially serious liver condition characterized by excess fat in the liver associated with inflammation and scarring. NASH may progress to cirrhosis of the ...

Researchers have shown that albino mice of the C57BL/6 line are highly susceptible to developing the inflammatory liver condition non-alcoholic steatohepatitis (NASH) when fed a high cholesterol diet.

The results of a newly reported study have confirmed that an amino acid compound developed by researchers at Michigan Medicine successfully treated nonalcoholic steatohepatitis (NASH) in non-human ...

The current role of lifestyle modification in regard to the management of patients with advanced fibrosis due to nonalcoholic steatohepatitis. Transcript Viviana Figueroa Diaz, MD: The standard of ...

The prevalence of non-alcoholic fatty liver disease (NAFLD), one of the most widespread disorders worldwide, is expected to rise by more than 50% by 2030. Non-alcoholic fatty liver (NAFL), the initial ...